Back to today’s briefing

Story perspectives

Precision Medicine Market to Hit $246.66 Billion by 2029

7/10/2025

36 6

Summary

Story summary

The precision medicine market is set to soar to $246.66 billion by 2029, fueled by an impressive 11.1% annual growth rate. Breakthroughs in AI and microbiome research are revolutionizing diagnostics, especially for colorectal cancer. Leading companies like F. Hoffman La Roche, Agilent Technologies, and Guardant Health are at the forefront of this transformative wave in personalized healthcare.

1 of 1

Story summary

The precision medicine market is set to soar to $246.66 billion by 2029, fueled by an impressive 11.1% annual growth rate. Breakthroughs in AI and microbiome research are revolutionizing diagnostics, especially for colorectal cancer. Leading companies like F. Hoffman La Roche, Agilent Technologies, and Guardant Health are at the forefront of this transformative wave in personalized healthcare.